FDA recalls another CareFusion infusion pump
(Reuters) - U.S. health regulators announced a recall of CareFusion's Alaris pump module Model 8100, saying a potential keypad malfunction in the infusion pump could cause serious injury or death.
The U.S. Food and Drug Administration said the affected pump modules, used for delivering a variety of fluids, drugs and blood products to patients, were manufactured between October 2011 and February 2012.
The FDA classified the action as a Class I recall on its website, meaning that the defective units could cause serious harm to a patient's health.
Earlier this month, the FDA had announced a Class I recall of another CareFusion pump, the Alaris PC unit Model 8015, citing a malfunction in its power supply board.
Shares of CareFusion closed at $26.61 on the New York Stock Exchange on Wednesday.
(Reporting by Balaji Sridharan in Bangalore; Editing by Anthony Kurian)
- WHO shuts Sierra Leone lab after worker infected with Ebola
- Poroshenko to seek ceasefire after 'very tough' talks with Putin |
- Islamic State executes soldiers, takes hostages at Syria base: social media
- Gaza ceasefire holding as focus turns to longer term |
- 'Men in green' raise suspicions of east Ukrainian villagers